Deaths from rectal cancer are rising rapidly among younger adults, an alarming trend that is confounding scientists trying to ...

For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient ...

Rushika M. Perera, the Deborah Cowan Professor and vice chair of the Department of Anatomy, and chief scientific officer of ...

In 2011, when Manjiri Bakre started her company, OncoStem, she was keen on developing a cost-effective, accurate, and ...

Cambridge, UK, 24th April 2026 - Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery and development of non-cereblon/non-VHL Targeted Glue™ degraders, today announces the ...

VANCOUVER, BC / ACCESS Newswire / April 23, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has ...

In today's Morning Rounds newsletter, a new era in GOP drug policy, an international childhood vaccine campaign grows, and ...

This version updates the headline which had a misspellingCEO Panna Sharma to Lead Live, Unscripted Platform Walkthrough ...

Teddi Mellencamp isn’t feeling like herself after gaining weight amid her cancer journey — so she tried to do something about ...

Singapore has signed the fourth iteration of the Country Programme Framework (CPF) 2026–2031 with the International Atomic ...

Regulatory Filing in Japan Planned Following Clinical Trial Completion -TOKYO and SAN DIEGO, April 24, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin Co., Ltd. (TSE: 4151, "Kyowa Kirin") and Kura Oncology, Inc.

Alvotech (NASDAQ: ALVO; ALVO-SDB) (the 'Company”), a global biotechnology company specializing in the development and ...